Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -514,770 | -509,366 | -25,293 | -6,944 | -26,379 |
| Depreciation Amortization | 117,992 | 78,155 | 38,573 | 146,486 | 107,497 |
| Income taxes - deferred | -55,316 | -46,663 | -1,832 | -20,731 | -13,743 |
| Accounts receivable | 15,967 | -6,540 | 21,451 | 7,398 | 38,861 |
| Other Working Capital | -18,388 | -42,686 | -24,654 | -31,007 | -19,020 |
| Other Operating Activity | 493,083 | 524,762 | -19,502 | 34,180 | -8,574 |
| Operating Cash Flow | $38,568 | $-2,338 | $-11,257 | $129,382 | $78,642 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,502 | -8,502 | -7,000 | 5,503 | -29,747 |
| PPE Investments | -64,222 | -49,066 | -28,920 | -104,418 | -74,818 |
| Net Acquisitions | N/A | N/A | N/A | -277,811 | -281,994 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -9,953 | N/A |
| Other Investing Activity | -432 | 0 | 0 | -14,082 | 0 |
| Investing Cash Flow | $-73,156 | $-57,568 | $-35,920 | $-390,808 | $-386,559 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 671,000 | 67,300 | 54,400 | 486,500 | 451,100 |
| Debt Repayment | -644,802 | -31,131 | -15,244 | -187,131 | -147,188 |
| Common Stock Issued | 957 | 957 | 957 | 6,398 | 6,398 |
| Common Stock Repurchased | -221 | -221 | N/A | -52,471 | -50,000 |
| Other Financing Activity | -22,941 | -22,667 | -4,736 | -15,433 | -15,297 |
| Financing Cash Flow | $3,993 | $14,238 | $35,377 | $237,863 | $245,013 |
| Exchange Rate Effect | 16,406 | 17,207 | 4,529 | -6,464 | 1,659 |
| Beginning Cash Position | 246,375 | 246,375 | 246,375 | 276,402 | 276,402 |
| End Cash Position | 232,186 | 217,914 | 239,104 | 246,375 | 215,157 |
| Net Cash Flow | $-14,189 | $-28,461 | $-7,271 | $-30,027 | $-61,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,568 | -2,338 | -11,257 | 129,382 | 78,642 |
| Capital Expenditure | -64,222 | -49,066 | -28,920 | -104,418 | -74,818 |
| Free Cash Flow | -25,654 | -51,404 | -40,177 | 24,964 | 3,824 |